Impax Asset Management Group’s Roivant Sciences ROIV Stock Holding History

Impax Asset Management Group’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.6M	Hold	300,000	–	–	0.07%	167
2026 Q1	$8.31M	Sell	300,000 -250,000	-45%	-$6.42M	0.06%	169
2025 Q4	$11.9M	Sell	550,000 -1,250,000	-69%	-$24.7M	0.07%	135
2025 Q3	$27.2M	Sell	1,800,000 -200,000	-10%	-$2.48M	0.16%	89
2025 Q2	$22.5M	Hold	2,000,000	–	–	0.13%	100
2025 Q1	$20.2M	Hold	2,000,000	–	–	0.12%	106
2024 Q4	$23.7M	Hold	2,000,000	–	–	0.11%	114
2024 Q3	$23.1M	Buy	2,000,000 +400,000	+25%	+$4.55M	0.09%	122
2024 Q2	$16.9M	Hold	1,600,000	–	–	0.07%	135
2024 Q1	$16.9M	Buy	+1,600,000	New	+$17.3M	0.06%	139

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Impax Asset Management Group's ROIV Position: Q2 2026 in Review

Impax Asset Management Group held its Roivant Sciences (ROIV) position steady in Q2 2026 at 300,000 shares worth $10.6M. The position accounts for 0.07% of the portfolio, ranked #167.

Impax Asset Management Group first reported a position in ROIV in Q1 2024 and has held it in 10 quarters since. The position peaked at $27.2M in Q3 2025. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Impax Asset Management Group held 300,000 shares of Roivant Sciences worth $10.6M as of Q2 2026.
Impax Asset Management Group left its Roivant Sciences share count unchanged in Q2 2026.
Roivant Sciences made up 0.07% of Impax Asset Management Group's portfolio in Q2 2026, its #167 holding.
Impax Asset Management Group first reported a position in Roivant Sciences in Q1 2024 and has held it in 10 quarters since.
Impax Asset Management Group's Roivant Sciences position peaked at $27.2M in Q3 2025.
498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Impax Asset Management Group's 13F filing for Q2 2026, filed 11 Aug 2026.